Literature DB >> 26369660

Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study.

Christian Roth1, Rudolf Berger2,3, Sabine Scherzer1, Lisa Krenn1, Clemens Gangl1, Daniel Dalos1, Georg Delle-Karth1,4, Thomas Neunteufl1,5,6.   

Abstract

Wire crossing of a chronic total coronary occlusion (CTO) is time consuming and limited by the amount of contrast agent and time of radiation exposure. Magnetic wire navigation (MWN) might accelerate wire crossing by maintaining a coaxial vessel orientation. This study compares MWN with the conventional approach for recanalization of CTOs. Forty symptomatic patients with CTO were randomised to MWN (n = 20) or conventional approach (n = 20) for antegrade crossing of the occlusion. In the intention-to-treat analysis, MWN showed a shorter crossing time (412 versus 1131 s; p = 0.001), and, consequently, lower usage of contrast agent (primary endpoint 42 versus 116 ml; p = 0.01), and lower radiation exposure (dose-area product: 29 versus 80 Gy*cm(2); p = 0.002) during wire crossing compared to the conventional approach. Accordingly, in the per-protocol analysis, the wire-crossing rate was, in trend, higher using the conventional approach (17 of 31) compared to MWN (9 of 28; p = 0.08). The use of MWN for revascularisation of CTOs is feasible and reduces crossing time, use of contrast agent, and radiation exposure. However, due to a broader selection of wires, the conventional approach enables wire crossing in cases failed by MWN and seems to be the more successful choice.

Entities:  

Keywords:  Chronic total occlusion (CTO); Complex lesions; Contrast media; Coronary artery disease (CAD); Revascularization

Mesh:

Substances:

Year:  2015        PMID: 26369660     DOI: 10.1007/s00380-015-0739-0

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  42 in total

Review 1.  A percutaneous treatment algorithm for crossing coronary chronic total occlusions.

Authors:  Emmanouil S Brilakis; J Aaron Grantham; Stéphane Rinfret; R Michael Wyman; M Nicholas Burke; Dimitri Karmpaliotis; Nicholas Lembo; Ashish Pershad; David E Kandzari; Christopher E Buller; Tony DeMartini; William L Lombardi; Craig A Thompson
Journal:  JACC Cardiovasc Interv       Date:  2012-04       Impact factor: 11.195

2.  The feasibility and safety of applying the Magnetic Navigation System to manage chronically occluded vessels: a single centre experience.

Authors:  Steve Ramcharitar; Willem J van der Giessen; Martin van der Ent; Pim de Feyter; Patrick W Serruys; Robert-Jan van Geuns
Journal:  EuroIntervention       Date:  2011-01       Impact factor: 6.534

3.  A randomized comparison of the magnetic navigation system versus conventional percutaneous coronary intervention.

Authors:  Steve Ramcharitar; Robert Jan van Geuns; Mark Patterson; Willem J van der Giessen; Martin van der Ent; Ron T van Domburg; Patrick W Serruys
Journal:  Catheter Cardiovasc Interv       Date:  2008-11-15       Impact factor: 2.692

4.  European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club.

Authors:  Carlo Di Mario; Gerald S Werner; Georgios Sianos; Alfredo R Galassi; Joachim Büttner; Dariusz Dudek; Bernard Chevalier; Thierry Lefevre; Joachim Schofer; Jacques Koolen; Horst Sievert; Bernhard Reimers; Jean Fajadet; Antonio Colombo; Anthony Gershlick; Patrick W Serruys; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2007-05       Impact factor: 6.534

5.  Magnetic navigation system assisted stenting of coronary bifurcation lesions.

Authors:  Cihan Simsek; Michael Magro; Mark S Patterson; Yoshinobu Onuma; Isabella Ciampichetti; Sander van Weenen; Ron T van Domburg; Patrick W Serruys; Eric Boersma; Robert-Jan van Geuns
Journal:  EuroIntervention       Date:  2011-03       Impact factor: 6.534

Review 6.  Radiation safety program for the cardiac catheterization laboratory.

Authors:  Charles E Chambers; Kenneth A Fetterly; Ralf Holzer; Pei-Jan Paul Lin; James C Blankenship; Stephen Balter; Warren K Laskey
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-19       Impact factor: 2.692

7.  Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions.

Authors:  Satya Reddy Atmakuri; Eli I Lev; Carlos Alviar; Edward Ibarra; Albert E Raizner; Stuart L Solomon; Neal S Kleiman
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

8.  Patient radiation doses in interventional cardiology in the U.S.: advisory data sets and possible initial values for U.S. reference levels.

Authors:  Donald L Miller; C Michael Hilohi; David C Spelic
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

9.  Use of the Stereotaxis Niobe magnetic navigation system for percutaneous coronary intervention: results from 350 consecutive patients.

Authors:  Ferdinand Kiemeneij; Mark S Patterson; Giovanni Amoroso; GertJan Laarman; Ton Slagboom
Journal:  Catheter Cardiovasc Interv       Date:  2008-03-01       Impact factor: 2.692

10.  Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel.

Authors:  David M Safley; John A House; Steven P Marso; J Aaron Grantham; Barry D Rutherford
Journal:  JACC Cardiovasc Interv       Date:  2008-06       Impact factor: 11.195

View more
  2 in total

1.  Application of a rapid exchange extension catheter technique in type B2/C nonocclusive coronary intervention via a transradial approach.

Authors:  Hong-Chao Wang; Wei Lu; Zi-Han Gao; Ya-Nan Xie; Jie Hao; Jin-Ming Liu
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

2.  Magnetic navigation system for percutaneous coronary intervention: A meta-analysis.

Authors:  Zhiyong Qi; Bangwei Wu; Xinping Luo; Jun Zhu; Haiming Shi; Bo Jin
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.